drugset / Trial / NCT00328822

Quetiapine for Primary Insomnia Patients : A Randomized Controlled Trial

NCT00328822 ↗

Completed 16 enrolled Khon Kaen University
RandomizedParallel-groupDouble-blindTreatment

Summary

Primary insomnia patients will sleep with Quetiapine not better than without Quetiapine

Timeline

Start
2006-12
Primary completion
—
Completion
2007-08

Outcome

Missed primary endpoint

paper Statistical significance was not reached between both groups. PMID 20572379 ↗

paper Quetiapine at 25 mg at night did show a trend for improvement of TST and reduced SL in primary insomnia with few side effects but not reaching statistical significance. PMID 20572379 ↗

Drugs

EvaluationDrugModalityDoseRoute
Subject Quetiapine Small molecule 25 mg —

Indications